Followers | 217 |
Posts | 15532 |
Boards Moderated | 2 |
Alias Born | 04/10/2013 |
Friday, October 21, 2016 1:10:39 PM
Recent GRPH News
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 03/08/2024 10:17:55 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/08/2024 10:13:02 PM
- Graphite Bio Declares Special Dividend In Connection with Proposed Merger with Lenz Therapeutics • Business Wire • 03/08/2024 10:00:00 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 03/05/2024 11:09:26 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2024 11:08:01 AM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/27/2024 09:11:05 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 02/13/2024 09:44:23 PM
- Form S-4/A - Registration of securities, business combinations: [Amend] • Edgar (US Regulatory) • 02/09/2024 10:23:14 PM
- Form S-4/A - Registration of securities, business combinations: [Amend] • Edgar (US Regulatory) • 02/05/2024 09:57:19 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/05/2024 09:31:56 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 12/26/2023 09:37:56 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/26/2023 09:32:30 PM
- Form S-4 - Registration of securities, business combinations • Edgar (US Regulatory) • 12/06/2023 09:57:38 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 11/15/2023 10:23:53 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 11/15/2023 01:09:02 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/15/2023 01:06:35 PM
- LENZ Therapeutics and Graphite Bio Announce Merger Agreement • Business Wire • 11/15/2023 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:08:44 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 09/13/2023 08:06:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/23/2023 08:06:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 09:04:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/02/2023 08:07:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/21/2023 09:13:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/21/2023 09:12:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/21/2023 09:05:36 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM